Microglia-Mediated Inflammation and Neurodegenerative Disease

Overview

Journal Mol Neurobiol

Specialties Molecular Biology
Neurology

Date 2015 Dec 15

PMID 26659872

Citations 155

Authors

Ling Xu

Dan He

Ying Bai

Affiliations

Soon will be listed here.

Abstract

Microglia are the main effectors in the inflammatory process of the central nervous system. As the first line of defense, microglia play an important role in the inflammatory reaction. When there is pathogen invasion or cell debris, microglia will be activated rapidly and remove it, while releasing the inflammatory cytokines to mediate inflammatory reaction. Activated microglia were found surrounding lesions of various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, muscular amyotrophic lateral sclerosis, and multiple sclerosis. Microglia, the effectors of neuronal degeneration and necrosis, are involved in the removal of necrotic neurons. But over activated microglia may accelerate the process of some neurodegenerative diseases. Activated microglia can release cytotoxic factor and cytokines. Some of them may cause further damage to neuron, and some of them can regulate inflammatory cells to gather to the lesion. Microglia-mediated inflammation was considered to be the possible mechanism for the occurrence or deterioration of neurodegenerative diseases. Therefore, inhibiting the activity of microglia appropriately may be an effective way for the treatment of neurodegenerative diseases.

Citing Articles

Spermidine Inhibits M1 Microglia Polarization in a Mouse Model of Parkinson's Disease and BV2 Cells via NF-κB/STAT-1 Pathway.

Shu J, Jiao Y, Wei W, Yan A Brain Behav. 2025; 15(3):e70410.

PMID: 40059454 PMC: 11891262. DOI: 10.1002/brb3.70410.

Enhancing autophagy mitigates LPS-induced neuroinflammation by inhibiting microglial M1 polarization and neuronophagocytosis.

Guo J, Li Y, Ma K, Su G Front Cell Neurosci. 2025; 19:1546848.

PMID: 40051676 PMC: 11882556. DOI: 10.3389/fncel.2025.1546848.

Transcriptomic Analysis Divulges Differential Expressions of Microglial Genes After Microglial Repopulation in Mice.

Hafeez M, Gao H, Ju F, Qi F, Li T, Zhang S Int J Mol Sci. 2025; 26(4).

PMID: 40003960 PMC: 11855859. DOI: 10.3390/ijms26041494.

Biology, Pathology, and Targeted Therapy of Exosomal Cargoes in Parkinson's Disease: Advances and Challenges.

Almasi F, Abbasloo F, Soltani N, Dehbozorgi M, Moghadam Fard A, Kiani A Mol Neurobiol. 2025; .

PMID: 39998798 DOI: 10.1007/s12035-025-04788-7.

Diffusion tensor imaging features of white matter pathways in the brain after COVID-19 infection.

Balsak S, Atasoy B, Yabul F, Akcay A, Yurtsever I, Daskaya H Radiologie (Heidelb). 2025; .

PMID: 39873704 DOI: 10.1007/s00117-024-01414-w.

References

Politis M, Wu K, Molloy S, Bain P, Chaudhuri K, Piccini P . Parkinson's disease symptoms: the patient's perspective. Mov Disord. 2010; 25(11):1646-51. DOI: 10.1002/mds.23135. View

Frohman E, Racke M, Raine C . Multiple sclerosis--the plaque and its pathogenesis. N Engl J Med. 2006; 354(9):942-55. DOI: 10.1056/NEJMra052130. View

Zhang Y, Fan Y, Wang M, Wang D, Li X . Atorvastatin attenuates the production of IL-1β, IL-6, and TNF-α in the hippocampus of an amyloid β1-42-induced rat model of Alzheimer's disease. Clin Interv Aging. 2013; 8:103-10. PMC: 3563315. DOI: 10.2147/CIA.S40405. View

Stadelmann C, Kerschensteiner M, Misgeld T, Bruck W, Hohlfeld R, Lassmann H . BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?. Brain. 2002; 125(Pt 1):75-85. DOI: 10.1093/brain/awf015. View

Wilkinson K, El Khoury J . Microglial scavenger receptors and their roles in the pathogenesis of Alzheimer's disease. Int J Alzheimers Dis. 2012; 2012:489456. PMC: 3362056. DOI: 10.1155/2012/489456. View

Kocur M, Schneider R, Pulm A, Bauer J, Kropp S, Gliem M . IFNβ secreted by microglia mediates clearance of myelin debris in CNS autoimmunity. Acta Neuropathol Commun. 2015; 3:20. PMC: 4383054. DOI: 10.1186/s40478-015-0192-4. View

Wang J, Bowen G, Zhou S, Cerny A, Zacharia A, Knipe D . Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J Virol. 2011; 86(4):2273-81. PMC: 3302371. DOI: 10.1128/JVI.06010-11. View

Coles J, Fryer T, Smielewski P, Chatfield D, Steiner L, Johnston A . Incidence and mechanisms of cerebral ischemia in early clinical head injury. J Cereb Blood Flow Metab. 2004; 24(2):202-11. DOI: 10.1097/01.WCB.0000103022.98348.24. View

Holley M, Kielian T . Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection. J Immunol. 2011; 188(3):1360-70. PMC: 3709259. DOI: 10.4049/jimmunol.1101660. View

10.

Glass C, Saijo K, Winner B, Marchetto M, Gage F . Mechanisms underlying inflammation in neurodegeneration. Cell. 2010; 140(6):918-34. PMC: 2873093. DOI: 10.1016/j.cell.2010.02.016. View

11.

Marinova-Mutafchieva L, Sadeghian M, Broom L, Davis J, Medhurst A, Dexter D . Relationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson's disease. J Neurochem. 2009; 110(3):966-75. DOI: 10.1111/j.1471-4159.2009.06189.x. View

12.

Hirsch E, Hunot S, Faucheux B, Agid Y, Mizuno Y, Mochizuki H . Dopaminergic neurons degenerate by apoptosis in Parkinson's disease. Mov Disord. 1999; 14(2):383-5. DOI: 10.1002/1531-8257(199903)14:2<383::aid-mds1037>3.0.co;2-f. View

13.

Tieu K, Ischiropoulos H, Przedborski S . Nitric oxide and reactive oxygen species in Parkinson's disease. IUBMB Life. 2003; 55(6):329-35. DOI: 10.1080/1521654032000114320. View

14.

Lin C, Lin J, Chen Y, Shen H, Wei L, Yeh Y . Hyaluronic acid inhibits the glial scar formation after brain damage with tissue loss in rats. Surg Neurol. 2009; 72 Suppl 2:S50-4. DOI: 10.1016/j.wneu.2009.09.004. View

15.

Yeomans J . Role of tegmental cholinergic neurons in dopaminergic activation, antimuscarinic psychosis and schizophrenia. Neuropsychopharmacology. 1995; 12(1):3-16. DOI: 10.1038/sj.npp.1380235. View

16.

Wilms H, Rosenstiel P, Sievers J, Deuschl G, Zecca L, Lucius R . Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. FASEB J. 2003; 17(3):500-2. DOI: 10.1096/fj.02-0314fje. View

17.

Dambach H, Hinkerohe D, Prochnow N, Stienen M, Moinfar Z, Haase C . Glia and epilepsy: experimental investigation of antiepileptic drugs in an astroglia/microglia co-culture model of inflammation. Epilepsia. 2013; 55(1):184-92. DOI: 10.1111/epi.12473. View

18.

Yang X, Hao Y, He G, Chen C, Wang Y, Zhang G . [Relationship between activation of microglia and Jaks phosphorylation induced by microwave irradiation]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2010; 28(6):401-4. View

19.

Liang J, Takeuchi H, Jin S, Noda M, Li H, Doi Y . Glutamate induces neurotrophic factor production from microglia via protein kinase C pathway. Brain Res. 2010; 1322:8-23. DOI: 10.1016/j.brainres.2010.01.083. View

20.

Yenari M, Xu L, Tang X, Qiao Y, Giffard R . Microglia potentiate damage to blood-brain barrier constituents: improvement by minocycline in vivo and in vitro. Stroke. 2006; 37(4):1087-93. DOI: 10.1161/01.STR.0000206281.77178.ac. View